3 Best Biotech Stocks to Buy in November
For income investors, building a diversified portfolio of dividend stocks should be a top priority. That's because owning a wide array of stocks that span numerous industries reduces your risk profile. A payout cut for a stock that produces 1% of your total dividend income is far less painful than a cut for a stock that accounts for 10% of it.
If your portfolio needs more exposure to the healthcare industry, here are three high-quality biotech dividend stocks that you should think about buying in November.
Image source: Getty Images.
Source Fool.com
